Inhibition of tissue-type plasminogen activator by conditioned medium from cultured human and porcine vascular endothelial cells.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  1983-01-27

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-291X(83)91161-0PMID 6404257
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Partial Characterization of a Fibrinolytic Inhibitor Produced by Cultured Endothelial Cells Derived from Human Umbilical Vein

  1982cited by this paper
• Activation of plasminogen by tissue activator is increased specifically in the presence of certain soluble fibrin(ogen) fragments.

  1982cited by this paper
• Platelet effects on tissue factor and fibrinolytic inhibition of cultured human fibroblasts and vascular cells.

  1982cited by this paper
• Characterization of a plasminogen activator secreted by cultured bovine aortic endothelial cells.

  1982cited by this paper
• Correction of various abnormalities in cultured porcine von Willebrand endothelial cells by inhibition of plasminogen-dependent protease activity

  1981cited by this paper
• Correction of various abnormalities in cultured porcine von Willebrand endothelial cells by inhibition of plasminogen-dependent protease activity.

  1981cited by this paper
• Immunological identification and comparison of plasminogen activator forms in cultured normal human endothelial cells and smooth muscle cells.

  1981cited by this paper
• Studies on plasminogen activator and other proteases in subcultured human vascular cells.

  1981cited by this paper
• An Inhibitor Of Plasminogen Activator In Rabbit Endothelial Cells

  1981cited by this paper
• Secretion of Plasminogen Activators by Cultured Bovine Endothelial Cells: Partial Purification, Characterization and Evidence for Multiple Forms

  1981cited by this paper
• Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.

  1981cited by this paper
• Plasminogen activator activity by cultured bovine aortic endothelial cells.

  1980cited by this paper
• Anchorage independent growth and plasminogen activator production by bovine endothelial cells

  1980cited by this paper
• Tetradecanoyl phorbol acetate stimulates latent collagenase production by cultured human endothelial cells.

  1980cited by this paper
• Comparative studies of the fibrinolytic activity of cultured vascular cells.

  1979cited by this paper
• Regulation of plasminogen activator secretion in mouse peritoneal macrophages. I. - Role of serum studied by a new spectrophotometric assay for plasminogen activators.

  1979cited by this paper
• Production of a fibrinolytic inhibitor by cultured endothelial cells derived from human umbilical vein.

  1978cited by this paper
• Concomitant secretion by transformed SVWI38-VA13-2RA cells of plasminogen activator(s) and substance (s) which prevent their detection.

  1978cited by this paper
• Synthesis of a fibrinolytic activator and inhibitor by endothelial cells.

  1977cited by this paper
• Hormone and neurotransmitter receptors in an established vascular endothelial cell line.

  1976cited by this paper
• Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

  1973cited by this paper
• Plasminogen: Purification from Human Plasma by Affinity Chromatography

  1970cited by this paper
• The histological localisation of fibrinolysin activator.

  1959cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• DNA Polymerase as Therapeutic Intervention for Treating Patients with Multiple Sclerosis

  2018cites this paper
• human plasma Demonstration of a fast-acting inhibitor of plasminogen activators in

  2011cites this paper
• endothelial cell-conditioned medium Activated protein C decreases plasminogen activator-inhibitor activity in

  2011cites this paper
• Sinusoidal obstruction syndrome (veno-occlusive disease, VOD/SOS) der Leber nach Hämatopoetischer Stammzelltransplantation: "Prospektive Evaluation relevanter Laborparameter zur Differentialdiagnose der

  2009cites this paper
• The fibrinolytic system in newborns and children.

  2006cites this paper
• Activities, localizations, and roles of serine proteases and their inhibitors in human brain tumor progression

  2005cites this paper
• Studies on rat mammary adenocarcinomas: a model for metastasis

  2004cites this paper
• Discovery of PAI-1 in plasma.

  2000cites this paper
• Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor

  2000cites this paper
• Plasminogen activator inhibitor type 1 in ischemic cardiomyopathy.

  1999cites this paper
• Markers of Thrombosis and Fibrinolysis

  1997cites this paper
• 小児期のtissue-type plasminogen activator (tPA) およびplasminogen activator inhibitor-1 (PAI-1) に関する研究

  1996cites this paper
• Alpha-thrombin stimulates urokinase production and DNA synthesis in cultured human cerebral microvascular endothelial cells.

  1995cites this paper
• Up-Regulated Expression of Plasminogen Activator Inhibitor-1 in Hep G2 Cells: Interrelationship between Insulin and Insulin-Like Growth Factor 1

  1995cites this paper
• Avian urokinase-type plasminogen activator (u-PA) lacks the putative binding site for plasminogen activator inhibitor (PAI) and is resistant to inhibition by human PAI-1 and PAI-2*

  1995cites this paper
• α-Thrombin Stimulates Urokinase Production and DNA Synthesis in Cultured Human Cerebral Microvascular Endothelial Cells

  1995cites this paper
• Amniotic fluid plasminogen activators and inhibitors and TAT-complex levels during 2nd trimester pregnancy and labour

  1995cites this paper
• Food intake, fibrinolysis and risk factors for cardiovascular disease : studies with special focus on plasminogen activator inhibitor type 1 (PAI-1)

  1993cites this paper
• Hormonal regulation of the fibrinolytic components in the ovary.

  1993cites this paper
• Expression of plasminogen activators and their inhibitors in human pancreatic carcinoma: immunohistochemical study.

  1993cites this paper
• Induction of Proteases and Their Inhibitors in Cell Lines of Different Metastatic Potentials and Activated Oncogenes

  1993cites this paper
• The Peritoneum

  1992cites this paper
• Proteinases and Proteinase Inhibitors

  1992cites this paper
• Role of plasminogen activator inhibitor on nephrotoxic nephritis and its modulation by tumor necrosis factor.

  1992cites this paper
• Thrombolytic Therapy in Arterial Disease. I: Available Agents

  1992cites this paper
• Cloning and characterization of mink plasminogen activator inhibitor type 1 (PAI-1) cDNA and the regulation of mink PAI-1 expression at mRNA level

  1992cites this paper
• Characterization and regulation of the urokinase receptor of human endothelial cells

  1992cites this paper
• SPARC induces the expression of type 1 plasminogen activator inhibitor in cultured bovine aortic endothelial cells.

  1991cites this paper
• Regulation of plasminogen activator production by endothelial cells: role in fibrinolysis and local proteolysis.

  1991cites this paper
• EXPRESSION IN CULTURED ENDOTHELIAL CELLS AND THE VESSEL WALL

  1991cites this paper
• Regulation of PAI-1 gene expression

  1991cites this paper
• The Fibrinolytic System of the Vessel Wall and Its Role in the Control of Thrombosis

  1990cites this paper
• Plasminogen activator activities in the ventral and dorsolateral prostatic lobes of aging fischer 344 rats

  1990cites this paper
• Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines.

  1990cites this paper
• Inhibition of tissue plasminogen activator activity by aspirin in vivo and its relationship to levels of tissue plasminogen activator inhibitor antigen, plasminogen activator and their complexes.

  1989cites this paper
• Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha.

  1989cites this paper
• The role of vascular endothelial cells in the regulation of fibrinolysis.

  1989cites this paper
• Inhibition of Tissue Plasminogen Activator Activity by Aspirin In Vivo and Its Relationship to Levels of Tissue Plasminogen Activator Antigen, Plasminogen Activator Inhibitor, and Their Complexes

  1989cites this paper
• Fibrinolysis in critically ill patients.

  1989cites this paper
• Purification of high and low molecular weight plasminogen activator inhibitor 1 from fibrosarcoma cell-line HT 1080 conditioned medium.

  1989cites this paper
• Regulation of tissue plasminogen activator expression.

  1989cites this paper
• Plasminogen activator inhibitor type 2 cDNA transfected into Chinese hamster ovary cells is stably expressed but not secreted

  1989cites this paper
• Plasminogen activators and inhibitors in amniotic fluid

  1989cites this paper
• Fibrinolysis in Critically III Patients

  1989cites this paper
• Some Biochemical Aspects of the Metastatic Dissemination of Tumor Cells

  1989cites this paper
• Bovine plasminogen activator inhibitor 1: specificity determinations and comparison of the active, latent, and guanidine-activated forms.

  1988cites this paper
• Evidence for a Discrete Binding Protein of Plasminogen Activator Inhibitor in Plasma

  1988cites this paper
• Type 1 Plasminogen Activator Inhibitor and Its Potential Influence on Thrombolytic Therapy

  1988cites this paper
• TUMOR NECROSIS FACTOR INCREASES THE PRODUCTION OF PLASMINOGEN ACTIVATOR INHIBITOR IN HUMAN ENDOTHELIAL CELLS IN VITRO AND IN RATS IN VIVO

  1988cites this paper
• [27] Tissue-type plasminogen activator and fast-acting plasminogen activator inhibitor in plasma

  1988cites this paper
• Plasminogen activators and their inhibitors.

  1988cites this paper
• Renal and Hepatic Handling of Endogenous Tissue-Type Plasminogen Activator (t-PA) and Its Inhibitor in Man

  1988cites this paper
• Tissue-type plasminogen activator and fast-acting plasminogen activator inhibitor in plasma.

  1988cites this paper
• [26] Plasminogen activators and their inhibitors

  1988cites this paper
• Plasminogen activators and their inhibitors: regulators of extracellular proteolysis and cell function.

  1988cites this paper
• Fibrinolytic properties of a human endothelial hybrid cell line (Ea.hy 926).

  1988cites this paper
• Plasminogen activation and lysis of blood clots induced by cells in vitro

  1988cites this paper
• Fibrinolytic properties of a human endothelial hybrid cell line (Ea.hy 926)

  1988cites this paper
• Regulation of the synthesis and secretion of plasminogen activators by endothelial cells.

  1988cites this paper
• Plasminogen Activator Inhibitor Activity in Bacterial Infection

  1988cites this paper
• Fibrinolytic Pathways and the Endothelium

  1987cites this paper
• [Anti-activator inhibitors of plasminogen].

  1987cites this paper
• Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1.

  1987cites this paper
• The placental type plasminogen activator inhibitor, PAI 2

  1987cites this paper
• Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells

  1987cites this paper
• Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells

  1987cites this paper
• On the Relationship Between Different Molecular Forms of the Fast Inhibitor of Tissue Plasminogen Activator

  1987cites this paper
• The Fibrinolytic System of Cultured Endothelial Cells

  1987cites this paper
• Plasminogen activator inhibitors.

  1987cites this paper
• Immunological Relationship Between Plasminogen Activator Inhibitors from Different Sources

  1987cites this paper
• Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors

  1987cites this paper
• Plasminogen activator inhibitor from human endothelial cells

  1987cites this paper
• Plasminogen activator inhibitors from placenta and fibrosarcoma cells are antigenically different as evaluated with monoclonal and polyclonal antibodies.

  1987cites this paper
• Conversion of the active to latent plasminogen activator inhibitor from human endothelial cells.

  1987cites this paper
• Plasminogen activator inhibitor from human endothelial cells. Purification and partial characterization.

  1987cites this paper
• Effect of Thrombin on the Production of Plasminogen Activators and PA Inhibitor-1 by Human Foreskin Microvascular Endothelial Cells

  1987cites this paper
• A Sensitive Assay, Specific for Endothelial Cell Type Plasminogen Activator Inhibitor in Blood Plasma

  1986cites this paper
• The fibrinolytic system in man.

  1986cites this paper
• Inhibition of one-chain and two-chain forms of human tissue-type plasminogen activator by the fast-acting inhibitor of plasminogen activator in vitro and in vivo.

  1986cites this paper
• Purification of an active plasminogen activator inhibitor immunologically related to the endothelial type plasminogen activator inhibitor from the conditioned media of a human melanoma cell line.

  1986cites this paper
• The active and the inactive plasminogen activator inhibitor from human endothelial cell conditioned medium are immunologically and functionally related to each other.

  1986cites this paper
• Monoclonal Antibodies Towards the Fast Inhibitor of Tissue Plasminogen Activator from Human Plasma and Serum

  1986cites this paper
• Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived components.

  1986cites this paper
• D-Phe-Pro-Arg-Chloromethylketone: Its Potential Use in Inhibiting the Formation of In Vitro Artifacts in Blood Collected During Tissue-Type Plasminogen Activator Thrombolytic Therapy

  1986cites this paper
• Blood Platelet Plasminogen Activator Inhibitor: Two Different Pools of Endothelial Cell Type Plasminogen Activator Inhibitor in Human Blood

  1986cites this paper
• Monoclonal Antibodies to Human 54,000 Molecular Weight Plasminogen Activator Inhibitor from Fibrosarcoma Cells - Inhibitor Neutralization and One-Step Affinity Purification

  1986cites this paper
• Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.

  1986cites this paper
• Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.

  1986cites this paper
• Rapid inactivation of the plasminogen-activator inhibitor upon secretion from cultured human endothelial cells.

  1986cites this paper
• Concepts of clot lysis.

  1986cites this paper
• Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.

  1986cites this paper
• Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937.

  1986cites this paper
• Effect of polymyxin B and colimycin on induction of plasminogen antiactivator by lipopolysaccharide in human endothelial cell culture

  1986cites this paper
• Release of plasminogen activator by cultured corneal epithelial cells during differentiation and wound closure.

  1986cites this paper
• Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells

  1986cites this paper
• Fibrinolysis: Its initiation and regulation

  1986cites this paper
• Inactivation of plasminogen activator inhibitor by oxidants.

  1986cites this paper
• Plasminogen activator inhibitors in plasma and platelets from patients with recurrent venous thrombosis and pregnant women.

  1986cites this paper
• Quantification of tissue-type plasminogen activator (t-PA) mRNA in human endothelial-cell cultures by hybridization with a t-PA cDNA probe.

  1986cites this paper
• Human Leucocyte Urokinase Inhibitor - Purification, Characterization and Comparative Studies Against Different Plasminogen Activators

  1985cites this paper